How to measure improvement in Long COVID iden
<p>Researchers have reached an agreement on how best to measure the severity and impact of Long COVID by identifying a “Core Outcome Measure Set” (COMS).</p>
Stay updated with breaking news from Nick Lemoine. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
<p>Researchers have reached an agreement on how best to measure the severity and impact of Long COVID by identifying a “Core Outcome Measure Set” (COMS).</p>
28.11.2022 - A drug used to reduce the risk of blood clots does not help patients recovering from moderate and severe COVID-19, despite this approach being offered to patients, a UK-wide trial, led by Addenbrooke's Hospital and the University of Cambridge has found.
A drug used to reduce the risk of blood clots does not help patients recovering from moderate and severe COVID-19, despite this approach being offered to patients, a UK-wide trial, led by Addenbrooke's Hospital and the University of Cambridge has found.
The HEAL-COVID trial (Helping to Alleviate the Longer-term consequences of COVID-19) is funded by the National Institute for Health and Care Research (NIHR)
The FINANCIAL -- Researchers from the University of Oxford have today reported findings from a large-scale study that examined the impact of the UK’s MenACWY vaccination programme on the carriage of meningitis bacteria in the throats of UK teenagers. They have demonstrated the impact of the vaccine in generating herd protection, also called herd immunity,The FINANCIAL -- Researchers from the University of Oxford have today reported findings from a large-scale study that examined the impact of the UK’s MenACWY vaccination programme on the carriage of meningitis bacteria in the throats of UK...